127 related articles for article (PubMed ID: 37909982)
1. Implication of TIPE2 Expression on the Malignant Transformation of Oral Leukoplakia.
Chen H; Pei M; Shin SW; Moon S; Nam W; Zheng Z
Anticancer Res; 2023 Nov; 43(11):4937-4946. PubMed ID: 37909982
[TBL] [Abstract][Full Text] [Related]
2. The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.
Xia RH; Song XM; Wang XJ; Li J; Mao L
PLoS One; 2013; 8(6):e66794. PubMed ID: 23826135
[TBL] [Abstract][Full Text] [Related]
3. Snail and Axin2 expression predict the malignant transformation of oral leukoplakia.
Zhang X; Kim KY; Zheng Z; Kim HS; Cha IH; Yook JI
Oral Oncol; 2017 Oct; 73():48-55. PubMed ID: 28939076
[TBL] [Abstract][Full Text] [Related]
4. Transglutaminase 3 contributes to malignant transformation of oral leukoplakia to cancer.
Wu X; Wang R; Jiao J; Li S; Yu J; Yin Z; Zhou L; Gong Z
Int J Biochem Cell Biol; 2018 Nov; 104():34-42. PubMed ID: 30172723
[TBL] [Abstract][Full Text] [Related]
5. Oral leukoplakia classification and staging system with incorporation of differentiated dysplasia.
Brouns ER; Evren I; Wils LJ; Poell JB; Brakenhoff RH; Bloemena E; de Visscher JGAM
Oral Dis; 2023 Oct; 29(7):2667-2676. PubMed ID: 35765231
[TBL] [Abstract][Full Text] [Related]
6. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.
Liu W; Wang YF; Zhou HW; Shi P; Zhou ZT; Tang GY
BMC Cancer; 2010 Dec; 10():685. PubMed ID: 21159209
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia.
Sakata J; Yoshida R; Matsuoka Y; Nagata M; Hirosue A; Kawahara K; Nakamura T; Nakamoto M; Hirayama M; Takahashi N; Nakashima H; Arita H; Ogi H; Hiraki A; Shinohara M; Nakayama H
Cancer Med; 2017 Apr; 6(4):730-738. PubMed ID: 28256094
[TBL] [Abstract][Full Text] [Related]
8. Malignant transformation of Taiwanese patients with oral leukoplakia: A nationwide population-based retrospective cohort study.
Wang TY; Chiu YW; Chen YT; Wang YH; Yu HC; Yu CH; Chang YC
J Formos Med Assoc; 2018 May; 117(5):374-380. PubMed ID: 29428194
[TBL] [Abstract][Full Text] [Related]
9. Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers.
Zhang X; Kim KY; Zheng Z; Bazarsad S; Kim J
Oral Oncol; 2017 Sep; 72():132-139. PubMed ID: 28797449
[TBL] [Abstract][Full Text] [Related]
10. [The expression and clinical significance of Bmi-1 gene in oral leukoplakia with different prognosis].
Wu XB; Wang RY; Gong SR; Zhu J; Zhu S
Zhonghua Yi Xue Za Zhi; 2022 Mar; 102(11):787-794. PubMed ID: 35325958
[No Abstract] [Full Text] [Related]
11. Clinicopathologic factors associated with malignant transformation of oral leukoplakias: a retrospective cohort study.
Jäwert F; Pettersson H; Jagefeldt E; Holmberg E; Kjeller G; Öhman J
Int J Oral Maxillofac Surg; 2021 Nov; 50(11):1422-1428. PubMed ID: 33674140
[TBL] [Abstract][Full Text] [Related]
12. Oral leukoplakia in the Sudan: clinicopathological features and risk factors.
Mustafa MB; Hassan MO; Alhussein A; Mamoun E; El Sheikh M; Suleiman AM
Int Dent J; 2019 Dec; 69(6):428-435. PubMed ID: 31407319
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia.
Liu W; Wu L; Shen XM; Shi LJ; Zhang CP; Xu LQ; Zhou ZT
Int J Cancer; 2013 Feb; 132(4):868-74. PubMed ID: 22782852
[TBL] [Abstract][Full Text] [Related]
14. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3β pathway.
Liu W; Yao Y; Shi L; Tang G; Wu L
J Cell Biochem; 2021 Oct; 122(10):1302-1312. PubMed ID: 33969929
[TBL] [Abstract][Full Text] [Related]
15. C-kit Expression in Oral Leukoplakia.
Tegginamani AS; Shivakumar VH; Ismail SMB; Abraham MT; Fernandes BA; Zamzuri ATB
J Coll Physicians Surg Pak; 2022 Feb; 32(2):256-258. PubMed ID: 35108805
[TBL] [Abstract][Full Text] [Related]
16. Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study.
Evren I; Brouns ER; Wils LJ; Poell JB; Peeters CFW; Brakenhoff RH; Bloemena E; de Visscher JGAM
Oral Oncol; 2020 Nov; 110():105014. PubMed ID: 33038723
[TBL] [Abstract][Full Text] [Related]
17. Malignant transformation of oral leukoplakia: Systematic review and meta-analysis of the last 5 years.
Aguirre-Urizar JM; Lafuente-Ibáñez de Mendoza I; Warnakulasuriya S
Oral Dis; 2021 Nov; 27(8):1881-1895. PubMed ID: 33606345
[TBL] [Abstract][Full Text] [Related]
18. Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study.
Liu W; Feng JQ; Shen XM; Wang HY; Liu Y; Zhou ZT
Cancer; 2012 Mar; 118(6):1693-700. PubMed ID: 22009787
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of nomogram for prediction of malignant transformation in oral leukoplakia: A large-scale cohort study.
Wang T; Wang L; Yang H; Lu H; Zhang J; Li N; Guo CB
J Oral Pathol Med; 2019 Jul; 48(6):491-498. PubMed ID: 30980769
[TBL] [Abstract][Full Text] [Related]
20. Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia.
Thiem DGE; Schneider S; Venkatraman NT; Kumar VV; Brieger J; Frerich B; Kämmerer PW
J Oral Pathol Med; 2017 Oct; 46(9):710-716. PubMed ID: 28036153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]